Bumper Offer - Urjas oil Just @ Rs. 1
Sporidex DT 250 Tablet (10) is a prescription medicine that is available as a Tablet. Bacterial Infections are some of its major therapeutic uses. Sporidex DT 250 Tablet (10) also has some secondary and off-label uses. These are listed below.
The right dosage of Sporidex DT 250 Tablet (10) depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Sporidex DT 250 Tablet (10) also has some side effects, the most common being Nausea or vomiting, Allergic reaction, Rash. Apart from the aforementioned side effects, Sporidex DT 250 Tablet (10) can also lead to other problems, which have been listed below. Normally, these side effects of Sporidex DT 250 Tablet (10) are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Sporidex DT 250 Tablet (10) is Safe for pregnant women and Safe for women who are breastfeeding. It is important to know if Sporidex DT 250 Tablet (10) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Sporidex DT 250 Tablet (10) related warnings section.
Other contraindications of Sporidex DT 250 Tablet (10) have been discussed in the sections ahead.
Drug interactions for Sporidex DT 250 Tablet (10) have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Sporidex DT 250 Tablet (10), it is important to know that it is safe while driving, and is habit-forming.
Sporidex DT 250 Tablet (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Sporidex DT 250 Tablet (10) is used -
Severe
Moderate
Mild
Common
Is the use of Sporidex DT 250 Tablet (10) safe for pregnant women?
There are no side effects of Sporidex in pregnant women.
Is the use of Sporidex DT 250 Tablet (10) safe during breastfeeding?
Sporidex does not show any side effects in breastfeeding women.
What is the effect of Sporidex DT 250 Tablet (10) on the Kidneys?
Sporidex may have mild side effects on the kidneys.
What is the effect of Sporidex DT 250 Tablet (10) on the Liver?
Using Sporidex does not have any harmful effects on the liver.
What is the effect of Sporidex DT 250 Tablet (10) on the Heart?
You can take Sporidex without any fear of damage to the heart.
Sporidex DT 250 Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Sporidex DT 250 Tablet (10) unless your doctor advises you to do so -
Is this Sporidex DT 250 Tablet (10) habit forming or addictive?
Forming a habit of Sporidex DT 250 Tablet (10) has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Sporidex DT 250 Tablet (10) will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Sporidex DT 250 Tablet (10) should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Sporidex DT 250 Tablet (10) for mental disorders.
Interaction between Food and Sporidex DT 250 Tablet (10)
Taking Sporidex DT 250 Tablet (10) with food does not cause any problems.
Interaction between Alcohol and Sporidex DT 250 Tablet (10)
It is difficult to say anything about the effect of Sporidex DT 250 Tablet (10) and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300